May 06, 2026

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis

Caris MI Clarity leverages AI to transform how recurrence risk is understood and applied in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer IRVING, Texas, May 5, 2026 /PRNewswire/ -- Caris Life Sciences®...

recent articles

Access to cloud-based platform during COVID-19 pandemic For pathologists and scientists who are working from home, and to enable remote working for those who are not currently able to practice social distancing measures due to a lack of...

San Jose, California -- OptraSCAN®, the leading On-Demand Digital Pathology solution provider will be demonstrating its patented PD-L1 companion research workbench using an Automated AI Toolset through a free webinar on 23rd April 2020....

Dr. Dan Peruzzi, stereology educator and staff scientist at MBF Bioscience, will be hosting an online question and answer session on unbiased stereology. Dr. Peruzzi will cover both theoretical and practical aspects regarding the use of...

Ft. Myers, Florida – NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused testing services, announces that it has integrated Indica Labs enterprise-level HALO AP™ image analysis platform for Image Analysis,...

OR

platinum partners

gold partners

Silver Partners

Media Partners